Currency headwinds stall J&J growth in Q2
This article was originally published in Clinica
Executive Summary
Unfavourable currency effects took a toll on Johnson & Johnson's results for the second quarter of 2012, as the company's top-line dipped 0.7% to $16.48bn. On a constant currency basis, revenue for the group increased 3.5%.